The U.S. Food and Drug Administration has approved Taiho Oncology's Inqovi (decitabine and cedazuridine) plus venetoclax for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) ...

Long-term RELAZA2 data showed MRD-guided therapy may improve outcomes for AML and MDS patients through earlier intervention.

Vanflyta® (quizartinib) is now publicly reimbursed in Canada in Quebec, enabling access for adult patients with newly diagnosed FLT3-ITD positive acute myeloid ...

Former Virginia football safety Donovan Johnson has died following a battle with cancer, UVA has announced. He was 25.

With the publication of the long-term data from the RELAZA2 study, a research program developed over many years by Dresden University Medicine for the treatment of leukemia patients, has reached an ...

After an acute myeloid leukemia diagnosis, Robert Hines reached remission and received a lifesaving stem cell transplant from ...

When Kendall Schara's body seemed unable to fight a simple infection, doctors knew something was wrong ...

The CEO said positive Regal data could potentially help GPS gain broader NCCN recognition beyond the current AML setting. ・Earlier GPS data showed median survival of 35.5 months in older AML patients ...

"They gave him a birthday memory that I truly believe he will carry with him for the rest of his life. As parents, we will ...

"I had never even heard of this diagnosis, and judging from my early symptoms, I never would have thought I had a serious ...

A young woman thought she was dealing with a stubborn cold — but it turned out to be an aggressive form of leukemia. Ayley ...

At Google I/O 2026, Google opened researcher registration for Hypothesis Generation — the first public-facing tool built on Co-Scientist, its multi-agent AI system for scientific hypothesis generation ...